Literature DB >> 1661171

No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus.

K Cornetta1, R A Morgan, A Gillio, S Sturm, L Baltrucki, R O'Reilly, W F Anderson.   

Abstract

Four monkeys were exposed to a retroviral vector and replication-competent murine amphotropic retrovirus in a bone marrow transplantation/gene transfer protocol (Kantoff et al., 1987). We have studied these animals 2 and 3 years post-transplantation and did not detect replicating virus in serum, peripheral blood mononuclear cells, or bone marrow cells. Amphotropic envelope sequences could not be detected in blood or bone marrow cells by Southern blotting or the polymerase chain reaction. Antibodies directed against the p30 and gp70 viral antigens were detected by Western blot and immunoprecipitation. The animals remain alive and well. Our findings suggest that primates can clear murine amphotropic retroviruses even when exposure occurs during a time of severe immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661171     DOI: 10.1089/hum.1991.2.3-215

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  20 in total

Review 1.  Retroviral vectors. From laboratory tools to molecular medicine.

Authors:  R G Vile; A Tuszynski; S Castleden
Journal:  Mol Biotechnol       Date:  1996-04       Impact factor: 2.695

Review 2.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

Review 3.  Prospects for gene therapy in sports medicine.

Authors:  T G Gerich; F H Fu; P D Robbins; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1996       Impact factor: 4.342

4.  Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors.

Authors:  Christian Metzl; Daniela Mischek; Brian Salmons; Walter H Günzburg; Matthias Renner; Daniel Portsmouth
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma.

Authors:  Chien-Kuo Tai; Wei Jun Wang; Thomas C Chen; Noriyuki Kasahara
Journal:  Mol Ther       Date:  2005-11       Impact factor: 11.454

6.  Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis.

Authors:  E F Vanin; M Kaloss; C Broscius; A W Nienhuis
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  No evidence of xenotropic murine leukemia virus-related virus transmission by blood transfusion from infected rhesus macaques.

Authors:  Dhanya K Williams; Teresa A Galvin; Yamei Gao; Christina O'Neill; Dustin Glasner; Arifa S Khan
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

Review 8.  Gene therapy on renal-cell carcinoma: magic bullet or tragic insanity?

Authors:  G H Mickisch
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

9.  Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.

Authors:  Christopher R Logg; Brian T Baranick; Nathan A Lemp; Noriyuki Kasahara
Journal:  J Mol Biol       Date:  2007-04-19       Impact factor: 5.469

Review 10.  From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists.

Authors:  G H Mickisch; F H Schroeder
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.